Filing Details

Accession Number:
0001415889-22-012654
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-19 07:14:23
Reporting Period:
2022-12-16
Accepted Time:
2022-12-19 07:14:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1719406 Nrx Pharmaceuticals Inc. NRXP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325232 H Stephen Willard C/O Nrx Pharmaceuticals Inc
1201 N. Market Street, Suite 111
Wilmington DE 19801
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2022-12-16 50,000 $1.17 50,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.20. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.